Timothy W Pontz

age ~55

from Seattle, WA

Also known as:
  • Timothy Pontz
  • Timothy William Pontz
  • Tim Pontz
  • Tmothy Pontz

Timothy Pontz Phones & Addresses

  • Seattle, WA
  • Shaw Island, WA
  • 138 Huron Ave, Cambridge, MA 02138 • 6179452007
  • Watertown, MA
  • Arlington, MA
  • Brighton, MA
  • Pittsburgh, PA
  • Plainsboro, NJ
  • Lancaster, PA
  • Somerville, MA

Us Patents

  • Chemical Compounds

    view source
  • US Patent:
    8461170, Jun 11, 2013
  • Filed:
    Aug 2, 2011
  • Appl. No.:
    13/196189
  • Inventors:
    Brian Aquila - Waltham MA,
    Victor Kamhi - Waltham MA,
    Bo Peng - Waltham MA,
    Timothy Pontz - Waltham MA,
    Jamal Carlos Saeh - Waltham MA,
    Kumar Thakur - Waltham MA,
    Bin Yang - Waltham MA,
  • Assignee:
    Astrazeneca AB - Sodertalje
  • International Classification:
    A01N 43/54
    A61K 31/505
  • US Classification:
    514275, 544330, 544333, 544334
  • Abstract:
    The present invention relates to compounds of Formula (I) and/or Formula (Ia):.
  • Substituted Quinazolones As Anti-Cancer Agents

    view source
  • US Patent:
    20080275022, Nov 6, 2008
  • Filed:
    Jun 14, 2005
  • Appl. No.:
    11/569918
  • Inventors:
    Brian Aquila - Marlborough MA,
    Les Dakin - Natick MA,
    Jayachandran Ezhuthachan - Brookline MA,
    John Lee - Harvard MA,
    Paul Lyne - Arlington MA,
    Timothy Pontz - Cambridge MA,
  • Assignee:
    AstraZeneca AB - Sodertalje
  • International Classification:
    A61K 31/517
    C07D 239/88
    C07D 413/02
    A61K 31/5377
    C07D 403/02
    A61P 35/00
  • US Classification:
    51421021, 544287, 5142663, 5142345, 544119
  • Abstract:
    The invention relates to chemical compounds of the formula (I): or pharmaceutically acceptable salts thereof, which possess B Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.
  • Substituted Quinazolines With Anti-Cancer Activity

    view source
  • US Patent:
    20090163525, Jun 25, 2009
  • Filed:
    Apr 4, 2007
  • Appl. No.:
    12/295820
  • Inventors:
    Brian A. Aquila - Waltham MA,
    Paul Lyne - Waltham MA,
    Timothy Pontz - Waltham MA,
  • Assignee:
    ASTRAZENECA AB - Sodertalje
  • International Classification:
    A61K 31/517
    C07D 239/80
    A61P 35/00
  • US Classification:
    5142663, 544287
  • Abstract:
    The invention relates to chemical compounds of the formula (I): or pharmaceutically acceptable salts thereof, which possess B Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.
  • Quinazolin-4-One Derivatives, Process For Their Preparation And Pharmaceutical Compositions Containing Them

    view source
  • US Patent:
    20090149484, Jun 11, 2009
  • Filed:
    Apr 17, 2007
  • Appl. No.:
    12/297336
  • Inventors:
    Brian Aquila - Waltham MA,
    Paul Lyne - Waltham MA,
    Timothy Pontz - Waltham MA,
  • Assignee:
    ASTRAZENECA AB - Sodertalje
  • International Classification:
    A61K 31/517
    C07D 239/72
    A61P 35/00
  • US Classification:
    5142661, 544283
  • Abstract:
    The invention relates to chemical compounds of the formula (I): or pharmaceutically acceptable salts thereof, which possess B-Raf inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm-blooded animal such as man.
  • Quinazolinone Derivatives And Their Use As B-Raf Inhibitors

    view source
  • US Patent:
    20090118261, May 7, 2009
  • Filed:
    Aug 26, 2005
  • Appl. No.:
    11/574031
  • Inventors:
    Brian Aquila - Waltham MA,
    Leslie Dakin - Waltham MA,
    Jayachandran Ezhuthachan - Waltham MA,
    Stephen Lee - Waltham MA,
    Paul Lyne - Waltham MA,
    Timothy Pontz - Waltham MA,
    XiaoLan Zheng - Waltham MA,
  • Assignee:
    ASTRAZENECA AB - Sodertalje
  • International Classification:
    A61K 31/55
    C07D 239/72
    A61K 31/517
    C07D 413/02
    A61K 31/5377
    A61P 35/00
    C07D 471/02
    A61K 31/519
    A61K 31/496
    C07D 403/02
  • US Classification:
    51421706, 544287, 5142663, 544116, 5142345, 544279, 5142641, 51425217, 540600
  • Abstract:
    The invention relates to chemical compounds of the formula (I): or pharmaceutically acceptable salts thereof, which possess B Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.
  • Enantiomers Of Selected Fused Heterocyclics And Uses Thereof

    view source
  • US Patent:
    20090099210, Apr 16, 2009
  • Filed:
    Dec 22, 2008
  • Appl. No.:
    12/340855
  • Inventors:
    Brian Aquila - Waltham MA,
    Michael Howard Block - Waltham MA,
    Audrey Davies - Waltham MA,
    Jayachandran Ezhuthachan - Brookline MA,
    Sandra Ann Filla - Waltham MA,
    Timothy Pontz - Waltham MA,
    Daniel John Russell - Waltham MA,
    Maria-Elena Theoclitou - Macclesfield,
    XiaoLan Zheng - Waltham MA,
  • Assignee:
    ASTRAZENECA AB - Sodertalje
  • International Classification:
    A61K 31/519
    A61P 35/00
  • US Classification:
    5142601
  • Abstract:
    This invention relates to novel compounds having the structural formula (I)and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
  • Quinazolinone Derivatives And Their Use As B-Raf Inhibitors

    view source
  • US Patent:
    20090054469, Feb 26, 2009
  • Filed:
    Aug 28, 2005
  • Appl. No.:
    11/574036
  • Inventors:
    Brian Aquila - Marlborough MA,
    Paul Lyne - Arlington MA,
    Timothy Pontz - Cambridge MA,
  • Assignee:
    ASTRAZENECA AB - Sodertalje
  • International Classification:
    A61K 31/517
    C07D 239/72
    A61P 35/04
  • US Classification:
    5142661, 544283
  • Abstract:
    The invention relates to chemical compounds of the formula (I): or pharmaceutically acceptable salts thereof, which possess B Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.
  • Quinazoline Derivatives, Process For Their Preparation And Their Use As Anti-Cancer Agents

    view source
  • US Patent:
    20080306096, Dec 11, 2008
  • Filed:
    Dec 19, 2006
  • Appl. No.:
    12/097965
  • Inventors:
    Brian Aquila - Marlborough MA,
    Jayachandran Ezhuthachan - Brookline MA,
    Paul Lyne - Arlington MA,
    Timothy Pontz - Cambridge MA,
    Xiaolan Zheng - Waltham MA,
  • Assignee:
    ASTRAZENECA AB - Sodertalje
  • International Classification:
    A61K 31/517
    A61P 35/00
    C07D 239/94
    C07D 403/12
    C07D 405/02
    C07D 409/02
    C07D 401/02
  • US Classification:
    51426622, 544293, 544284, 5142664, 51426623, 51426624
  • Abstract:
    The invention relates to chemical compounds of the formula (I) or pharmaceutically acceptable salts thereof, which possess B Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.

Mylife

Timothy Pontz Photo 1

Timothy Ptz Bright MA

view source
Locate Timothy Pontz or anyone else from your past. See what friends like ...

Get Report for Timothy W Pontz from Seattle, WA, age ~55
Control profile